Your browser doesn't support javascript.
loading
Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models.
Lim, Ye Seul; Yoo, Sun-Mi; Patil, Vineet; Kim, Han Wool; Kim, Hyun-Hwi; Suh, Beomseon; Park, Ji Youn; Jeong, Na-Rae; Park, Chi Hoon; Ryu, Je Ho; Lee, Byung-Hoon; Kim, Pilho; Lee, Song Hee.
Afiliação
  • Lim YS; Ubix Therapeutics, Seoul, Republic of Korea.
  • Yoo SM; Ubix Therapeutics, Seoul, Republic of Korea.
  • Patil V; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Kim HW; Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon, Republic of Korea.
  • Kim HH; Ubix Therapeutics, Seoul, Republic of Korea.
  • Suh B; Ubix Therapeutics, Seoul, Republic of Korea.
  • Park JY; Ubix Therapeutics, Seoul, Republic of Korea.
  • Jeong NR; Ubix Therapeutics, Seoul, Republic of Korea.
  • Park CH; Ubix Therapeutics, Seoul, Republic of Korea.
  • Ryu JH; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Lee BH; Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon, Republic of Korea.
  • Kim P; Ubix Therapeutics, Seoul, Republic of Korea.
  • Lee SH; Department of New Biology, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Republic of Korea.
Blood Adv ; 7(1): 92-105, 2023 01 10.
Article em En | MEDLINE | ID: mdl-36269842

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2023 Tipo de documento: Article